APOE and Alzheimer disease: Defective lipid metabolism is now confirmed to relate to AD through the discovery that carriers of the apolipoprotein E type 4 (APOE4) allele, involved in lipid transport and metabolism, convey an elevated risk of both sporadic and late-onset familial AD (Corder et al., 1993).